- Home
- PLRX vs CTO Comparison
PLRX vs CTO Comparison
Compare PLRX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | CTO |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.1M | 599.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLRX | CTO |
|---|---|---|
| Price | $1.30 | $19.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.67 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 415.1K | 180.9K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 7.73% |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.63 |
| Revenue Next Year | N/A | $2.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $15.07 |
| 52 Week High | $1.95 | $20.25 |
Technical Indicators
Market Signals| Indicator | PLRX | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 65.12 |
| Support Level | $1.12 | $19.16 |
| Resistance Level | $1.36 | $19.82 |
| Average True Range (ATR) | 0.07 | 0.31 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 68.75 | 96.63 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.